SAFETY, PHARMACOKINETICS AND PHARMACODYNAMICS OF THE NOVEL ORAL PEPTIDE THERAPEUTIC PTG-100 (ALPHA4-BETA7 INTEGRIN ANTAGONIST) IN NORMAL HEALTHY VOLUNTEERS
Richard Shames 1
Lucio Tozzi 1
Larry Mattheakis 1
THAMIL ANNAMALAI 1
ASHOK BHANDARI 1
David Liu 2
1 PROTAGONIST THERAPEUTICS, Milpitas, United States of America
2 PROTAGONIST THERAPEUTICS,
Conference
UEG Week 2016
Citation
United European Gastroenterology Journal; 2016: 2 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
Social Sharing